Paradigm shift: combination BET and JAK inhibition in myelofibrosis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2021-12, Vol.35 (12), p.3361-3363
Hauptverfasser:	Mascarenhas, John, Gerds, Aaron, Verstovsek, Srdan
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1990/2331 692/308/153 Anemia Animals Bone marrow Cancer Cancer Research Critical Care Medicine Drug therapy Gene expression Genetic aspects Hematology Humans Intensive Internal Medicine Janus Kinases - antagonists & inhibitors Kinases Leukemia Medicine Medicine & Public Health Mutation Myelofibrosis Oncology Patients Perspective Primary Myelofibrosis - drug therapy Primary Myelofibrosis - metabolism Primary Myelofibrosis - pathology Protein Kinase Inhibitors - therapeutic use Proteins Proteins - antagonists & inhibitors RNA polymerase Spleen Telomerase Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!